Reversal of rocuronium-induced fixed pupillary dilation by sugammadex in ICU patients with COVID-19.

Winant, Maxime; Engel, Harald; Dubois, Pauline; Halenarova, Katarina; De Backer, Daniel

Winant, Maxime; Engel, Harald; Dubois, Pauline; Halenarova, Katarina; De Backer, Daniel.

Afiliação

Winant M; Intensive Care Unit, CHIREC Hospital Group, Université Libre de Bruxelles, Brussels, Belgium; Intensive Care Unit, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: maxime.winant@stpierre-bru.be.
Engel H; Intensive Care Unit, CHIREC Hospital Group, Université Libre de Bruxelles, Brussels, Belgium.
Dubois P; Department of Ophthalmology, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Halenarova K; Intensive Care Unit, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
De Backer D; Intensive Care Unit, CHIREC Hospital Group, Université Libre de Bruxelles, Brussels, Belgium.

Br J Anaesth ; 132(3): 627-629, 2024 Mar.

Article em En | MEDLINE | ID: mdl-38218692

Assuntos

COVID-19; Bloqueio Neuromuscular; Humanos; Sugammadex/farmacologia; Rocurônio; Dilatação; Unidades de Terapia Intensiva; Androstanóis

Palavras-chave

COVID-19 ARDS; pupillary dilation; rocuronium infusion; rocuronium side-effect; sugammadex reversal

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bloqueio Neuromuscular / COVID-19 Limite: Humans Idioma: En Revista: Br J Anaesth Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google